PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
2016 · The Lancet Diabetes & Endocrinology · 384 citations
https://doi.org/10.1016/s2213-8587(16)30396-5
M
Max Moldovan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
109
Papers
4.4K
Citations
25
h-index
45
i10-index
Max Moldovan is an academic researcher from South Australian Health and Medical Research Institute. The author has contributed to research in topics: Metabolomics and Mass Spectrometry Studies & Cancer, Lipids, and Metabolism & Healthcare Quality and Management. The author has an h-index of 25, co-authored 93 publications.
ORCID: 0000-0001-9680-8474Papers by this author
worksCausal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus
2017 · Circulation · 350 citations
https://doi.org/10.1161/circulationaha.116.026560
Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9
2019 · BMC Cardiovascular Disorders · 47 citations
https://doi.org/10.1186/s12872-019-1187-z
Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants
2018 · Molecular & Cellular Proteomics · 36 citations
https://doi.org/10.1074/mcp.ra118.000633
The risk of fall-related hospitalisations at entry into permanent residential aged care
2021 · BMC Geriatrics · 21 citations
https://doi.org/10.1186/s12877-021-02640-w
Evaluation of current Australian health services accreditation processes (ACCREDIT-CAP): a protocol for a mixed method research project
2012 · Figshare · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat